Nyika Aceme
African Malaria Network Trust (AMANET), Dar es Salaam, Tanzania.
Acta Trop. 2009 Nov;112 Suppl 1:S32-6. doi: 10.1016/j.actatropica.2009.08.010. Epub 2009 Aug 13.
The disease burden in Africa, which is relatively very large compared with developed countries, has been attributed to various factors that include poverty, food shortages, inadequate access to health care and unaffordability of Western medicines to the majority of African populations. Although for 'old diseases' knowledge about the right African traditional medicines to treat or cure the diseases has been passed from generation to generation, knowledge about traditional medicines to treat newly emerging diseases has to be generated in one way or another. In addition, the existing traditional medicines have to be continuously improved, which is also the case with Western scientific medicines. Whereas one school of thought supports the idea of improving medicines, be they traditional or Western, through scientific research, an opposing school of thought argues that subjecting African traditional medicines to scientific research would be tantamount to some form of colonization and imperialism. This paper argues that continuing to use African traditional medicines for old and new diseases without making concerted efforts to improve their efficacy and safety is unethical since the disease burden affecting Africa may continue to rise in spite of the availability and accessibility of the traditional medicines. Most importantly, the paper commends efforts being made in some African countries to improve African traditional medicine through a combination of different mechanisms that include the controversial approach of scientific research on traditional medicines.
与发达国家相比,非洲的疾病负担相对非常沉重,这归因于多种因素,包括贫困、粮食短缺、获得医疗保健的机会不足以及大多数非洲人口无力负担西药。尽管对于“旧病”,有关治疗或治愈这些疾病的正确非洲传统药物的知识已代代相传,但对于治疗新出现疾病的传统药物的知识必须以某种方式加以创造。此外,现有的传统药物必须不断改进,西药也是如此。一种观点支持通过科学研究来改进药物,无论是传统药物还是西药,而另一种相反的观点则认为,对非洲传统药物进行科学研究无异于某种形式的殖民主义和帝国主义。本文认为,在没有共同努力提高其疗效和安全性的情况下,继续将非洲传统药物用于新旧疾病是不道德的,因为尽管有传统药物可用且可及,但影响非洲的疾病负担可能会继续上升。最重要的是,本文赞扬一些非洲国家通过包括对传统药物进行科学研究这种有争议的方法在内的不同机制相结合来改进非洲传统药物所做的努力。